Edwards Lifesciences net income up on heart valve sales

Oct 26 (Reuters) - Edwards Lifesciences Corp on Monday reported stronger-than-expected third-quarter earnings on demand for its replacement heart valves that are implanted in minimally invasive procedures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.